CAR T-cell therapy is an effective treatment for aggressive subtypes of follicular lymphoma, according to a clinical trial published in Nature Medicine. Follicular lymphoma is a typically slow-growing ...

Hard-to-detect colorectal pre-cancerous lesions known as serrated polyps, and the aggressive tumors that develop from them, depend heavily on the ramped-up production of cholesterol, according to a ...

Stephen Greene, MD, discusses the future and practical implications of optimizing quadruple foundational therapies for patients with heart failure. Recent advancements in medical therapy for heart ...

New research suggests that CAR T therapy, an effective treatment for certain relapsed B cell cancers, could potentially be used to treat children with aggressive T cell leukemia. In recent years, CAR ...

In a new study, scientists at Shanghai Jiaotong University School of Medicine found a promising new way to treat a type of oral cancer known as oral squamous cell carcinoma. The method specifically ...

Non-Hodgkin lymphoma (NHL) is a group of hematologic malignancies that originate from lymphocytes known as B or T cells. This occurs in the lymphatic system and is commonly characterized by swollen ...

A new tumor infiltrating lymphocyte therapy has achieved accelerated FDA approval for use in people who have run out of treatment options after their skin cancer spreads. The FDA has granted ...

—There was no significant difference in invasive disease-free survival between patients with human epidermal growth factor receptor 2-positive (HER2+) T1micN0 breast cancer who were and were not ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Although current American College of Rheumatology guidelines eschew treat-to-target for axial ...

Please provide your email address to receive an email when new articles are posted on . Pre-exposure prophylaxis with Evusheld, combined with aggressive outpatient treatment, may reduce COVID-19 ...